Bayer AG And Cipla Limited Settle Trademark Suit-Reuters

Reuters reported that Bayer AG's healthcare unit has settled trademark infringement cases with Cipla Limited and Vanuatu based website operator Archipelago Suppliers concerning the German drugmaker's pet products. Bayer HealthCare LLC said Cipla's DA Double Advantage pet treatment violated the trademark rights of its flea preventative, Advantage. Bayer had sought to block future sales of the product in the United States. Under the settlement, Cipla will surrender all profits it made from the sale of its DA Double Advantage, amounting in excess of $100,000, and discontinue all use of the trademark. Bayer received an additional $100,000 as reimbursement for attorneys' fees, and Cipla agreed to recall any product remaining in the sales pipeline.